Australia issues mental health alert on weight-loss drugs as WHO sets new guidelines
Australia’s Therapeutic Goods Administration (TGA) issued updated safety warnings for GLP-1 receptor agonists, a fast-growing class of diabetes and weight-loss medicines, even as the World Health Organization released its first-ever global guideline on using these drugs to treat obesity. The TGA alert recently issued updates product information for all GLP-1 and GIP/GLP-1 receptor agonists currently […]